Sid Snot
11-24

Where is the support line for astera 

Astera Labs Initiated at Outperform with $225 Price Target by BNP Paribas Exane
Astera Labs has been initiated with an 'Outperform' rating by BNP Paribas Exane. Additionally, BNP Paribas Exane has set a price target of $225.00 per share for Astera Labs. This indicates a positive outlook on the company's stock performance.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment